1. Home
  2. WAI vs SCLX Comparison

WAI vs SCLX Comparison

Compare WAI & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAI
  • SCLX
  • Stock Information
  • Founded
  • WAI 2018
  • SCLX 2011
  • Country
  • WAI China
  • SCLX United States
  • Employees
  • WAI N/A
  • SCLX N/A
  • Industry
  • WAI
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAI
  • SCLX Health Care
  • Exchange
  • WAI NYSE
  • SCLX Nasdaq
  • Market Cap
  • WAI 56.8M
  • SCLX 51.3M
  • IPO Year
  • WAI 2023
  • SCLX N/A
  • Fundamental
  • Price
  • WAI $0.20
  • SCLX $0.24
  • Analyst Decision
  • WAI
  • SCLX Strong Buy
  • Analyst Count
  • WAI 0
  • SCLX 4
  • Target Price
  • WAI N/A
  • SCLX $14.00
  • AVG Volume (30 Days)
  • WAI 333.0K
  • SCLX 1.1M
  • Earning Date
  • WAI 05-24-2025
  • SCLX 05-12-2025
  • Dividend Yield
  • WAI N/A
  • SCLX N/A
  • EPS Growth
  • WAI N/A
  • SCLX N/A
  • EPS
  • WAI N/A
  • SCLX N/A
  • Revenue
  • WAI $3,989,698.00
  • SCLX $56,590,000.00
  • Revenue This Year
  • WAI N/A
  • SCLX $24.19
  • Revenue Next Year
  • WAI N/A
  • SCLX $109.90
  • P/E Ratio
  • WAI N/A
  • SCLX N/A
  • Revenue Growth
  • WAI N/A
  • SCLX 22.02
  • 52 Week Low
  • WAI $0.19
  • SCLX $0.21
  • 52 Week High
  • WAI $1.55
  • SCLX $2.30
  • Technical
  • Relative Strength Index (RSI)
  • WAI N/A
  • SCLX 32.75
  • Support Level
  • WAI N/A
  • SCLX $0.22
  • Resistance Level
  • WAI N/A
  • SCLX $0.29
  • Average True Range (ATR)
  • WAI 0.00
  • SCLX 0.03
  • MACD
  • WAI 0.00
  • SCLX -0.00
  • Stochastic Oscillator
  • WAI 0.00
  • SCLX 13.14

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: